LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | GW843682X | 0.37 | uM | LJP6 | 72 | hr | 929 | 1074 | 3228 | 0.3329 | 0.0633 |
Hs 578T | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 929 | 2663 | 3228 | 0.8250 | 0.7542 |
Hs 578T | HG-5-88-01 | 0.37 | uM | LJP6 | 72 | hr | 929 | 2918 | 3228 | 0.9041 | 0.8653 |
Hs 578T | Imatinib | 0.37 | uM | LJP6 | 72 | hr | 929 | 3333 | 3228 | 1.0325 | 1.0456 |
Hs 578T | JNK-9L | 0.37 | uM | LJP6 | 72 | hr | 929 | 2930 | 3228 | 0.9079 | 0.8706 |
Hs 578T | JW-7-24-1 | 0.37 | uM | LJP6 | 72 | hr | 929 | 2608 | 3228 | 0.8081 | 0.7306 |
Hs 578T | Lapatinib | 0.37 | uM | LJP6 | 72 | hr | 929 | 3087 | 3228 | 0.9563 | 0.9386 |
Hs 578T | LDN-193189 | 0.37 | uM | LJP5 | 72 | hr | 929 | 2947 | 3228 | 0.9130 | 0.8779 |
Hs 578T | Linifanib | 0.37 | uM | LJP6 | 72 | hr | 929 | 3052 | 3228 | 0.9455 | 0.9234 |
Hs 578T | Linsitinib | 0.37 | uM | LJP5 | 72 | hr | 929 | 2995 | 3228 | 0.9279 | 0.8988 |
Hs 578T | Mitoxantrone | 0.37 | uM | LJP5 | 72 | hr | 929 | 935 | 3228 | 0.2897 | 0.0025 |
Hs 578T | Mitoxantrone | 0.37 | uM | LJP6 | 72 | hr | 929 | 894 | 3228 | 0.2770 | -0.0153 |
Hs 578T | MK2206 | 0.37 | uM | LJP6 | 72 | hr | 929 | 1743 | 3228 | 0.5400 | 0.3540 |
Hs 578T | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 929 | 2418 | 3228 | 0.7493 | 0.6479 |
Hs 578T | Nilotinib | 0.37 | uM | LJP5 | 72 | hr | 929 | 3705 | 3228 | 1.1480 | 1.2078 |
Hs 578T | Nintedanib | 0.37 | uM | LJP6 | 72 | hr | 929 | 2350 | 3228 | 0.7280 | 0.6180 |
Hs 578T | NU7441 | 0.37 | uM | LJP5 | 72 | hr | 929 | 2959 | 3228 | 0.9168 | 0.8831 |
Hs 578T | Dactolisib | 0.37 | uM | LJP5 | 72 | hr | 929 | 1307 | 3228 | 0.4050 | 0.1645 |
Hs 578T | NVP-TAE684 | 0.37 | uM | LJP6 | 72 | hr | 929 | 2237 | 3228 | 0.6932 | 0.5692 |
Hs 578T | Palbociclib | 0.37 | uM | LJP6 | 72 | hr | 929 | 1791 | 3228 | 0.5550 | 0.3752 |
Hs 578T | PD0325901 | 0.37 | uM | LJP5 | 72 | hr | 929 | 1618 | 3228 | 0.5014 | 0.2999 |
Hs 578T | PD0325901 | 0.37 | uM | LJP6 | 72 | hr | 929 | 1591 | 3228 | 0.4930 | 0.2880 |
Hs 578T | PD173074 | 0.37 | uM | LJP6 | 72 | hr | 929 | 2869 | 3228 | 0.8890 | 0.8441 |
Hs 578T | PD184352 | 0.37 | uM | LJP5 | 72 | hr | 929 | 2014 | 3228 | 0.6240 | 0.4720 |
Hs 578T | Pelitinib | 0.37 | uM | LJP5 | 72 | hr | 929 | 2918 | 3228 | 0.9042 | 0.8654 |